TOLERO PHARMACEUTICALS, INC.

Organization

SANDY, UT, US

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Combination therapies for treatment of cancer
- Patent number 10,682,356
- Issue date Jun 16, 2020
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Predicting response to alvocidib by mitochondrial profiling
- Patent number 10,624,880
- Issue date Apr 21, 2020
- Tolero Pharmaceuticals, Inc.
- Steven L. Warner
- G01 - MEASURING TESTING
Information Patent Grant
Combination therapies for treatment of cancer
- Patent number 10,568,887
- Issue date Feb 25, 2020
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alvocidib prodrugs having increased bioavailability
- Patent number 10,562,925
- Issue date Feb 18, 2020
- Tolero Pharmaceuticals, Inc.
- Adam Siddiqui-Jain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
PKM2 modulators and methods for their use
- Patent number 10,472,328
- Issue date Nov 12, 2019
- Tolero Pharmaceuticals, Inc.
- Koc-Kan Ho
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,422,788
- Issue date Sep 24, 2019
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors
- Patent number 10,392,392
- Issue date Aug 27, 2019
- Tolero Pharmaceuticals, Inc.
- Yong Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Predicting response to alvocidib by mitochondrial profiling
- Patent number 10,357,488
- Issue date Jul 23, 2019
- Tolero Pharmaceuticals, Inc.
- Steven L. Warner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,267,787
- Issue date Apr 23, 2019
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Alvocidib prodrugs having increased bioavailability
- Patent number 10,259,835
- Issue date Apr 16, 2019
- Tolero Pharmaceuticals, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PKM2 modulators and methods for their use
- Patent number 10,207,996
- Issue date Feb 19, 2019
- Tolero Pharmaceuticals, Inc.
- Koc-Kan Ho
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
JAK2 and ALK2 inhibitors and methods for their use
- Patent number 10,202,356
- Issue date Feb 12, 2019
- Tolero Pharmaceuticals, Inc.
- Alexis Mollard
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Profiling peptides and methods for sensitivity profiling
- Patent number 10,132,797
- Issue date Nov 20, 2018
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors
- Patent number 10,047,093
- Issue date Aug 14, 2018
- Tolero Pharmaceuticals, Inc.
- Yong Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Predicting response to alvocidib by mitochondrial profiling
- Patent number 9,901,574
- Issue date Feb 27, 2018
- Tolero Pharmaceuticals, Inc.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Alvocidib prodrugs having increased bioavailability
- Patent number 9,758,539
- Issue date Sep 12, 2017
- Tolero Pharmaceuticals, Inc.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multiple kinase pathway inhibitors
- Patent number 9,714,247
- Issue date Jul 25, 2017
- Tolero Pharmaceuticals, Inc.
- Qingping Zeng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Multiple kinase pathway inhibitors
- Patent number 9,493,454
- Issue date Nov 15, 2016
- Tolero Pharmaceuticals, Inc.
- Qingping Zeng
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors
- Patent number 9,416,132
- Issue date Aug 16, 2016
- Tolero Pharmaceuticals, Inc.
- Yong Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
PKM2 modulators and methods for their use
- Patent number 9,394,257
- Issue date Jul 19, 2016
- Tolero Pharmaceuticals, Inc.
- Koc-Kan Ho
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Imidazo[1,2-B]pyridazine and pyrazolo[1 .5-A]pyrimidine derivatives...
- Patent number 8,710,057
- Issue date Apr 29, 2014
- Tolero Pharmaceuticals, Inc.
- David J. Bearss
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS
- Publication number 20200338076
- Publication date Oct 29, 2020
- TOLERO PHARMACEUTICALS, INC.
- Steven L. WARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALK5 INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROME
- Publication number 20200323851
- Publication date Oct 15, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS TO TARGET TRANSCRIPTIONAL CONTROL AT SUPER-ENHANCER REGIONS
- Publication number 20200316084
- Publication date Oct 8, 2020
- TOLERO PHARMACEUTICALS, INC.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING PKM2 MODULATORS AND METHODS OF TREATMENT US...
- Publication number 20200297698
- Publication date Sep 24, 2020
- TOLERO PHARMACEUTICALS, INC.
- Steven L. WARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION-SENSITIVE...
- Publication number 20200281949
- Publication date Sep 10, 2020
- TOLERO PHARMACEUTICALS, INC.
- Steven L. WARNER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLIN-DEPENDENT KINASE INHIBITORS IN COMBINATION WITH ANTHRACYCLIN...
- Publication number 20200276174
- Publication date Sep 3, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT REGIMEN FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBIT...
- Publication number 20200276215
- Publication date Sep 3, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. BEARSS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATM...
- Publication number 20200255462
- Publication date Aug 13, 2020
- TOLERO PHARMACEUTICALS, INC.
- Adam SIDDIQUI-JAIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PKM2 ACTIVATORS IN COMBINATION WITH REACTIVE OXYGEN SPECIES FOR TRE...
- Publication number 20200237766
- Publication date Jul 30, 2020
- TOLERO PHARMACEUTICALS, INC.
- Adam SIDDIQUI-JAIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES FOR TREATMENT OF CANCER
- Publication number 20200215071
- Publication date Jul 9, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
- Publication number 20200200737
- Publication date Jun 25, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
- Publication number 20200131210
- Publication date Apr 30, 2020
- TOLERO PHARMACEUTICALS, INC.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PKM2 MODULATORS AND METHODS FOR THEIR USE
- Publication number 20200109120
- Publication date Apr 9, 2020
- TOLERO PHARMACEUTICALS, INC.
- Koc-Kan Ho
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS
- Publication number 20200102313
- Publication date Apr 2, 2020
- TOLERO PHARMACEUTICALS, INC.
- Yong Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR TREATING DISEASES ASSOCIATED WITH ABNORMAL ACVR1 EXPRES...
- Publication number 20200085823
- Publication date Mar 19, 2020
- TOLERO PHARMACEUTICALS, INC.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES FOR TREATMENT OF CANCER
- Publication number 20200054642
- Publication date Feb 20, 2020
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALVOCIDIB PRODRUGS AND THEIR USE AS PROTEIN KINASE INHIBITORS
- Publication number 20200048228
- Publication date Feb 13, 2020
- TOLERO PHARMACEUTICALS, INC.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CYCLIN-DEPENDENT KINASE INHIBITORS IN COMBINATION WITH ANTHRACYCLIN...
- Publication number 20190314357
- Publication date Oct 17, 2019
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
- Publication number 20190282557
- Publication date Sep 19, 2019
- TOLERO PHARMACEUTICALS, INC.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
- Publication number 20190177350
- Publication date Jun 13, 2019
- TOLERO PHARMACEUTICALS, INC.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
- Publication number 20190178873
- Publication date Jun 13, 2019
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PKM2 MODULATORS AND METHODS FOR THEIR USE
- Publication number 20190119219
- Publication date Apr 25, 2019
- TOLERO PHARMACEUTICALS, INC.
- Koc-Kan Ho
- C07 - ORGANIC CHEMISTRY
Information Patent Application
JAK2 AND ALK2 INHIBITORS AND METHODS FOR THEIR USE
- Publication number 20190119221
- Publication date Apr 25, 2019
- TOLERO PHARMACEUTICALS, INC.
- Alexis Mollard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS
- Publication number 20190071446
- Publication date Mar 7, 2019
- TOLERO PHARMACEUTICALS, INC.
- Yong Xu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING
- Publication number 20190030017
- Publication date Jan 31, 2019
- TOLERO PHARMACEUTICALS, INC.
- Steven L. Warner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
- Publication number 20180299432
- Publication date Oct 18, 2018
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS TO TARGET TRANSCRIPTIONAL CONTROL AT SUPER-ENHANCER REGIONS
- Publication number 20180280407
- Publication date Oct 4, 2018
- TOLERO PHARMACEUTICALS, INC.
- Steven L. Warner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPIES FOR TREATMENT OF CANCER
- Publication number 20180256580
- Publication date Sep 13, 2018
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING
- Publication number 20180172673
- Publication date Jun 21, 2018
- TOLERO PHARMACEUTICALS, INC.
- David J. Bearss
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY
- Publication number 20170334938
- Publication date Nov 23, 2017
- TOLERO PHARMACEUTICALS, INC.
- Adam Siddiqui-Jain
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

Information Trademark
86418815 - TOLERO PHARMACEUTICALS
- Serial number 86418815
- Registration number 4751574
- Filing date Oct 8, 2014
- Tolero Pharmaceuticals, Inc.
- 42 - Scientific and technological services and research and design relating thereto

TOLERO PHARMACEUTICALS, INC.

Organization

Patents Grantslast 30 patents

Combination therapies for treatment of cancer

Predicting response to alvocidib by mitochondrial profiling

Combination therapies for treatment of cancer

Alvocidib prodrugs having increased bioavailability

PKM2 modulators and methods for their use

Profiling peptides and methods for sensitivity profiling

Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors

Predicting response to alvocidib by mitochondrial profiling

Profiling peptides and methods for sensitivity profiling

Alvocidib prodrugs having increased bioavailability

PKM2 modulators and methods for their use

JAK2 and ALK2 inhibitors and methods for their use

Profiling peptides and methods for sensitivity profiling

Substituted imidazo[1,2-B]pyridazines as protein kinase inhibitors

Predicting response to alvocidib by mitochondrial profiling

Alvocidib prodrugs having increased bioavailability

Multiple kinase pathway inhibitors

Multiple kinase pathway inhibitors

Substituted imidazo[1,2-b]pyridazines as protein kinase inhibitors

PKM2 modulators and methods for their use

Imidazo[1,2-B]pyridazine and pyrazolo[1 .5-A]pyrimidine derivatives...

Patents Applicationslast 30 patents

FORMULATIONS COMPRISING HETEROCYCLIC PROTEIN KINASE INHIBITORS

ALK5 INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROME

METHODS TO TARGET TRANSCRIPTIONAL CONTROL AT SUPER-ENHANCER REGIONS

COMPOSITIONS COMPRISING PKM2 MODULATORS AND METHODS OF TREATMENT US...

METHODS FOR TREATING CASTRATION-RESISTANT AND CASTRATION-SENSITIVE...

CYCLIN-DEPENDENT KINASE INHIBITORS IN COMBINATION WITH ANTHRACYCLIN...

TREATMENT REGIMEN FOR CANCERS THAT ARE INSENSITIVE TO BCL-2 INHIBIT...

CDK9 INHIBITORS AND POLYMORPHS THEREOF FOR USE AS AGENTS FOR TREATM...

PKM2 ACTIVATORS IN COMBINATION WITH REACTIVE OXYGEN SPECIES FOR TRE...

COMBINATION THERAPIES FOR TREATMENT OF CANCER

PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING

ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY

PKM2 MODULATORS AND METHODS FOR THEIR USE

SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS

METHODS FOR TREATING DISEASES ASSOCIATED WITH ABNORMAL ACVR1 EXPRES...

COMBINATION THERAPIES FOR TREATMENT OF CANCER

ALVOCIDIB PRODRUGS AND THEIR USE AS PROTEIN KINASE INHIBITORS

CYCLIN-DEPENDENT KINASE INHIBITORS IN COMBINATION WITH ANTHRACYCLIN...

PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING

ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY

PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING

PKM2 MODULATORS AND METHODS FOR THEIR USE

JAK2 AND ALK2 INHIBITORS AND METHODS FOR THEIR USE

SUBSTITUTED IMIDAZO[1,2-B]PYRIDAZINES AS PROTEIN KINASE INHIBITORS

PREDICTING RESPONSE TO ALVOCIDIB BY MITOCHONDRIAL PROFILING

PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING

METHODS TO TARGET TRANSCRIPTIONAL CONTROL AT SUPER-ENHANCER REGIONS

COMBINATION THERAPIES FOR TREATMENT OF CANCER

PROFILING PEPTIDES AND METHODS FOR SENSITIVITY PROFILING

ALVOCIDIB PRODRUGS HAVING INCREASED BIOAVAILABILITY

Trademarklast 30 trademarks

86418815 - TOLERO PHARMACEUTICALS